NMRA: Neumora Therapeutics Inc
NMRA exchange rate has changed by -0.78% for today. During the day, the instrument was traded at a low of 2.40 and at a high of 2.64.
Follow Neumora Therapeutics Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
NMRA News
- Neumora Therapeutics, Inc. (NMRA) Discusses NMRA-215 Preclinical Results and Portfolio Updates, Including Obesity and Alzheimer's Disease Programs - Slideshow (NASDAQ:NMRA) 2025-10-27
- Neumora Therapeutics, Inc. (NMRA) Discusses NMRA-215 Preclinical Results and Portfolio Updates, Including Obesity and Alzheimer's Disease Programs Transcript
- Neumora Therapeutics stock jumps after positive obesity drug data
- Guggenheim upgrades Neumora Therapeutics stock to Buy on obesity data
- Neumora initiates phase 1 study of second M4 PAM compound
- Neumora’s obesity drug shows up to 26% weight loss in preclinical studies
- H.C. Wainwright maintains Buy rating on Neumora stock ahead of obesity drug data
- JPM downgrades Neumora, cites risk of more negative trial news
- Stifel maintains Hold rating on Neumora Therapeutics stock at $2.00
- Neumora Therapeutics, Inc. (NMRA) Q2 2025 Earnings Call Transcript
- Neumora (NMRA) Q2 Loss Improves 10%
- Boston Beer Posts Better-Than-Expected Earnings, Joins Scholastic, Deckers Outdoor, Saia And Other Big Stocks Moving Higher On Friday - Aon (NYSE:AON), Bel Fuse (NASDAQ:BELFA)
- Neumora Therapeutics soars 68% following InvestingPro’s June Fair Value signal
- Mizuho raises Neumora Therapeutics stock price target on new drug candidate
- H.C. Wainwright reiterates Buy rating on Neumora Therapeutics stock
- Neumora begins phase 1 trial of schizophrenia drug NMRA-861
- NMRA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Neumora Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
- ROSEN, LEADING INVESTOR COUNSEL, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - NMRA
- ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - NMRA
- Johnson & Johnson Stops Late-Stage Depression Study Over 'Insufficient Efficacy' - Johnson & Johnson (NYSE:JNJ)
- Neumora Therapeutics shares fall as company adjusts depression drug trials
- Neumora Therapeutics, Inc. (NMRA) Q4 2024 Earnings Call Transcript
Frequently Asked Questions
What is NMRA stock price today?
Neumora Therapeutics Inc stock is priced at 2.56 today. It trades within 2.40 - 2.64, yesterday's close was 2.58, and trading volume reached 2418. The live price chart of NMRA shows these updates.
Does Neumora Therapeutics Inc stock pay dividends?
Neumora Therapeutics Inc is currently valued at 2.56. Dividend policy depends on the company, while investors also watch -74.14% and USD. View the chart live to track NMRA movements.
How to buy NMRA stock?
You can buy Neumora Therapeutics Inc shares at the current price of 2.56. Orders are usually placed near 2.56 or 2.86, while 2418 and 2.40% show market activity. Follow NMRA updates on the live chart today.
How to invest into NMRA stock?
Investing in Neumora Therapeutics Inc involves considering the yearly range 0.61 - 11.57 and current price 2.56. Many compare -15.51% and 271.01% before placing orders at 2.56 or 2.86. Explore the NMRA price chart live with daily changes.
What are Neumora Therapeutics, Inc. stock highest prices?
The highest price of Neumora Therapeutics, Inc. in the past year was 11.57. Within 0.61 - 11.57, the stock fluctuated notably, and comparing with 2.58 helps spot resistance levels. Track Neumora Therapeutics Inc performance using the live chart.
What are Neumora Therapeutics, Inc. stock lowest prices?
The lowest price of Neumora Therapeutics, Inc. (NMRA) over the year was 0.61. Comparing it with the current 2.56 and 0.61 - 11.57 shows potential long-term entry points. Watch NMRA moves on the chart live for more details.
When did NMRA stock split?
Neumora Therapeutics Inc has gone through stock splits historically. These changes are visible in , 2.58, and -74.14% after corporate actions.
- Previous Close
- 2.58
- Open
- 2.50
- Bid
- 2.56
- Ask
- 2.86
- Low
- 2.40
- High
- 2.64
- Volume
- 2.418 K
- Daily Change
- -0.78%
- Month Change
- -15.51%
- 6 Months Change
- 271.01%
- Year Change
- -74.14%